Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence

NCT02496403 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02496403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence
Lead sponsor
Kaiser Permanente
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2015
Completion date
May 31, 2019
Enrollment
239 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opiate substitution treatment